We focused efforts in this study to RBM45 since it exhibited the most statistically significant p value and highest effect size between the ALS and control groups, was known to be developmentally regulated in the nervous system, contained structural similarities to TDP-43 and FUS, and commercial antibodies were available. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.